Publications by authors named "Heng-Ming Sung"
Article Synopsis
- COVID-19 increases the risk of thromboembolic events like stroke and heart issues, but vaccines seem to reduce this risk.
- A study found that receiving a bivalent mRNA COVID-19 vaccine after an original monovalent one significantly decreases the likelihood of these events, showing a vaccine effectiveness of 47% for those aged 65 and older, and 51% for younger adults with severe kidney disease.
- Overall, staying updated with COVID-19 vaccinations is crucial for preventing complications related to the virus, especially thromboembolic events.
Background: Shingrix (recombinant zoster vaccine) was licensed to prevent herpes zoster, dispensed as 2 doses given 2-6 months apart among adults aged ≥50 years. Clinical trials yielded efficacy of >90% for confirmed herpes zoster, but post-market performance has not been evaluated. Efficacy of a single dose and a delayed second dose and efficacy among persons with autoimmune or immunosuppressive conditions have not been studied.
View Article and Find Full Text PDFBackground: Studies have found that the high-dose influenza vaccine has a higher relative vaccine effectiveness (RVE) versus standard-dose vaccines in some seasons. We evaluated the effect of age on the RVE of high-dose versus standard-dose influenza vaccines among Medicare beneficiaries.
Methods: A 6-season retrospective cohort study from 2012 to 2018 among Medicare beneficiaries aged ≥65 years was performed.